|
ID |
DDInter1600 |
Drug Type |
small molecule |
Molecular Formula |
C20H19Fn8O2 |
Molecular Weight |
422.424
|
Description |
Riociguat is a stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
|
ATC Classification |
C02KX05
|
IUPAC Name |
Methyl N-(4,6-Diamino-2-{1-[(2-Fluorophenyl)Methyl]-1H-Pyrazolo[3,4-B]Pyridin-3-Yl}Pyrimidin-5-Yl)-N-Methylcarbamate |
InChI |
Inchi=1S/C20H19Fn8O2/C1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/H3-9H,10H2,1-2H3,(H4,22,23,25,26) |
InChI Key |
WXXSNCNJFUAIDG-UHFFFAOYSA-N |
Canonical SMILES |
COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2 |
Useful Links |
DrugBank
ChEMBL
PubChem
|